ArticleJournal of the American Chemical Society2018

Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists.

Matthew D Morin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.